Literature DB >> 16446120

The importance of parental expectations of cognitive improvement for their children with epilepsy prior to starting the ketogenic diet.

Sharifeh Farasat1, Eric H Kossoff, Diana J Pillas, James E Rubenstein, Eileen P Vining, John M Freeman.   

Abstract

Although the success rates and complications of various treatment options for children with intractable epilepsy have been described, the actual expectations of parents for these treatments are less clear. Since 1998, parents at our institution have written their goals in a letter before starting their children on the ketogenic diet. One hundred consecutive letters were evaluated. The most common first goal was seizure improvement, second was anticonvulsant reduction, and third was cognitive improvement. Ninety percent requested improvement in cognition or alertness. These expectations were either met or exceeded at 6 months in 52-60% of children. Achieving or surpassing parental expectations for cognitive improvement correlated with longer diet duration (P=0.04), but meeting goals for seizure or anticonvulsant reduction did not. Cognitive improvement (P<0.001) and >90% seizure reduction (P=0.04) at 6 months positively correlated with longer eventual diet duration. Expectations for cognitive improvement need to be discussed prior to beginning the ketogenic diet.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16446120     DOI: 10.1016/j.yebeh.2005.12.002

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  8 in total

1.  Dietary and medication adjustments to improve seizure control in patients treated with the ketogenic diet.

Authors:  Jessica H Selter; Zahava Turner; Sarah C Doerrer; Eric H Kossoff
Journal:  J Child Neurol       Date:  2014-05-22       Impact factor: 1.987

Review 2.  The changing face of dietary therapy for epilepsy.

Authors:  Ludovica Pasca; Valentina De Giorgis; Joyce Ann Macasaet; Claudia Trentani; Anna Tagliabue; Pierangelo Veggiotti
Journal:  Eur J Pediatr       Date:  2016-09-01       Impact factor: 3.183

Review 3.  The effects of the ketogenic diet on behavior and cognition.

Authors:  Tove Hallböök; Sunggoan Ji; Stuart Maudsley; Bronwen Martin
Journal:  Epilepsy Res       Date:  2011-08-27       Impact factor: 3.045

Review 4.  What constitutes a relevant animal model of the ketogenic diet?

Authors:  Gregory L Holmes
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

5.  Dietary enrichment with medium chain triglycerides (AC-1203) elevates polyunsaturated fatty acids in the parietal cortex of aged dogs: implications for treating age-related cognitive decline.

Authors:  Ameer Y Taha; Samuel T Henderson; W M Burnham
Journal:  Neurochem Res       Date:  2009-03-20       Impact factor: 3.996

6.  Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.

Authors:  Eric H Kossoff; Beth A Zupec-Kania; Stéphane Auvin; Karen R Ballaban-Gil; A G Christina Bergqvist; Robyn Blackford; Jeffrey R Buchhalter; Roberto H Caraballo; J Helen Cross; Maria G Dahlin; Elizabeth J Donner; Orkide Guzel; Rana S Jehle; Joerg Klepper; Hoon-Chul Kang; Danielle A Lambrechts; Y M Christiana Liu; Janak K Nathan; Douglas R Nordli; Heidi H Pfeifer; Jong M Rho; Ingrid E Scheffer; Suvasini Sharma; Carl E Stafstrom; Elizabeth A Thiele; Zahava Turner; Maria M Vaccarezza; Elles J T M van der Louw; Pierangelo Veggiotti; James W Wheless; Elaine C Wirrell
Journal:  Epilepsia Open       Date:  2018-05-21

Review 7.  Influence of the Mediterranean and Ketogenic Diets on Cognitive Status and Decline: A Narrative Review.

Authors:  Federica Vinciguerra; Marco Graziano; Maria Hagnäs; Lucia Frittitta; Andrea Tumminia
Journal:  Nutrients       Date:  2020-04-08       Impact factor: 5.717

8.  The CORE-KDT study: a mixed methods protocol to establish core outcomes for refractory childhood epilepsy treated with ketogenic diet therapy.

Authors:  Jennifer H Carroll; J Helen Cross; Mary Hickson; Emma Williams; Valerie Aldridge; Avril Collinson
Journal:  Trials       Date:  2022-08-17       Impact factor: 2.728

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.